More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$37586497
P/E ratio
7.4
Dividend yield
1.4922%
Expense ratio
0.65%
Beta
0.913282
Previous close
$46.02
Today's open
$46.04
Day's range
$43.60 - $46.04
52 week range
$16.76 - $48.18
Industries
Health
ERAS
Erasca Inc.
2.18%
1.89%
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Seeking Alpha • May 2, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.
Seeking Alpha • Apr 12, 2026

Can Forgotten Biotech Break Out?
After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.
Seeking Alpha • Apr 11, 2026

Biotech ETF (BBC) Touches Fresh 52-Week High
Biotech ETF BBC hits a 52-week high, likely fueled by strong clinical trial results and rising M&A activity, and renewed risk-on sentiment.
Zacks Investment Research • Apr 10, 2026

Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026?
Wall Street put up a modest show in the final quarter of 2025, with the S&P 500 advancing only 1.9%, the Dow Jones gaining 3.3% and the Nasdaq Composite adding about 2.1%. The small-cap index Russell 2000 added 1.6% during that period.
Zacks Investment Research • Jan 6, 2026

Biotech ETF (BBC) Hits New 52-Week High
Biotech ETF BBC hits a 52-week high amid renewed sector momentum, Fed rate cuts and AI-driven healthcare gains, hinting at more near-term upside.
Zacks Investment Research • Dec 1, 2025

Best-Performing ETFs of Last Week: Healthcare Rules
Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.
Zacks Investment Research • Nov 24, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Seeking Alpha • Nov 11, 2025

Trade War or Not, Specific Industry ETFs Are in Sweet Spots
Trade war jitters rise, but ETFs like MSOS, SILJ, SGDJ, BBC, WISE & CTEX shine on solid fundamentals, offering either safe havens or growth potential.
Zacks Investment Research • Oct 16, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Seeking Alpha • May 30, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Virtus LifeSci Biotech Clinical Trials ETF commission-free¹. Build wealth for the long term using automated trading and transfers.